Our data indicate that blockage of galectin-receptor interactions may increase the activity of liver CD68+ macrophages in the erythrocytic stage of malaria, which is in agreement with the increased parasitemia and tissue parasite burden in malarial mice with α-lactose treatment. This evidence concerns the gene CD68 and parasitic infectious disease.